Clinical trials of endothelin antagonists in heart failure: publication is good for the public health

Heart. 2007 Jan;93(1):2-4. doi: 10.1136/hrt.2006.089250.

Abstract

The failure of endothelin antagonists to show benefit in heart failure cannot be understood until all the clinical trials are fully published.

Publication types

  • Editorial

MeSH terms

  • Antihypertensive Agents / therapeutic use*
  • Clinical Trials as Topic*
  • Endothelin A Receptor Antagonists*
  • Endothelin-1 / physiology
  • Evidence-Based Medicine
  • Heart Failure / drug therapy*
  • Humans
  • Publishing

Substances

  • Antihypertensive Agents
  • Endothelin A Receptor Antagonists
  • Endothelin-1